There is currently no clinically useful screening test available to identify nulliparous women at high risk of developing pre-eclampsia. This study aimed to identify novel biomarkers using hypothesis generating proteomic methods applied to plasma samples obtained prior to clinical diagnosis of pre-eclampsia.Plasma samples taken at 15 weeks gestation from women who subsequently developed late pre-eclampsia (>34 weeks), early pre-eclampsia (
| Date of Award | 28 May 2012 |
|---|
| Original language | English |
|---|
| Awarding Institution | - The University of Manchester
|
|---|
- Pre-eclampsia
- Proteomics
- Biomarker
Quantitative Analysis of the Plasma Proteome in Pre-eclampsia
Fisher, C. (Author). 28 May 2012
Student thesis: Phd